BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34665703)

  • 1. Combined seronegativity in Sjögren's syndrome.
    Chatzis LG; Pezoulas V; Voulgari PV; Baldini C; Exarchos TP; Fotiadis DI; Mavragani CP; Skopouli FN; Moutsopoulos HM; Tzioufas AG; Goules AV
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):80-84. PubMed ID: 34665703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren's syndrome: a comparative study.
    Bodakçi E
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1760-1767. PubMed ID: 38497858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-center study of clinical features of pediatric Sjögren's syndrome.
    Hou L; Wang N; Zhao C; Wang X; Du Y
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):119. PubMed ID: 37833819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
    Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
    Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
    J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
    Huo AP; Lin KC; Chou CT
    Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjögren's syndrome: data from a nationwide cohort for Sjögren's syndrome in Korea.
    Park Y; Lee J; Koh JH; Sung YK; Lee SS; Choe JY; Shim SC; Kim JM; Kwon SR; Kim HO; Chung SH; Park SH; Kwok SK
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):107-113. PubMed ID: 31376264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical phenotype of primary Sjögren's syndrome patients with lymphadenopathy.
    Stergiou IE; Chatzis LG; Pezoulas VC; Baldini C; Fotiadis DI; Voulgarelis M; Tzioufas AG; Goules AV
    Clin Exp Rheumatol; 2022 Dec; 40(12):2357-2362. PubMed ID: 36541237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Diagnostic Performance of Early Sjögren's Syndrome Autoantibodies in Juvenile Sjögren's Syndrome: The University of Florida Pediatric Cohort Study.
    Thatayatikom A; Jun I; Bhattacharyya I; Berg K; Lee YJ; Kim Y; Adewumi A; Zhang W; Thatayatikom S; Shah A; Beal C; Modica R; Elder ME; Cha S
    Front Immunol; 2021; 12():704193. PubMed ID: 34249010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
    Acar-Denizli N; Horváth IF; Mandl T; Priori R; Vissink A; Hernandez-Molina G; Armagan B; Praprotnik S; Sebastian A; Bartoloni E; Rischmueller M; Pasoto SG; Nordmark G; Nakamura H; Fernandes Moça Trevisani V; Retamozo S; Carsons SE; Maure-Noia B; Sánchez-Berná I; López-Dupla M; Fonseca-Aizpuru E; Melchor Díaz S; Vázquez M; Díaz Cuiza PE; de Miguel Campo B; Ng WF; Rasmussen A; Dong X; Li X; Baldini C; Seror R; Gottenberg JE; Kruize AA; Sandhya P; Gandolfo S; Kwok SK; Kvarnstrom M; Solans R; Sene D; Suzuki Y; Isenberg DA; Valim V; Hofauer B; Giacomelli R; Devauchelle-Pensec V; Atzeni F; Gheita TA; Morel J; Izzo R; Kalyoncu U; Szántó A; Olsson P; Bootsma H; Ramos-Casals M; Kostov B; Brito-Zerón P;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):85-94. PubMed ID: 33095152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
    Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
    Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and serological characteristics of seronegative primary Sjögren's syndrome: a comparative study.
    Yazisiz V; Aslan B; Erbasan F; Uçar İ; Öğüt TS; Terzioğlu ME
    Clin Rheumatol; 2021 Jan; 40(1):221-229. PubMed ID: 32504193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
    Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
    Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological and hematological characteristics of Sjogren's syndrome and dry eye syndrome patients using a novel immune serology technique.
    Ben-Eli H; Solomon A; Aframian DJ; Ben-Chetrit E; Mevorach D; Kleinstern G; Waterboer T; Willhauck-Fleckenstein M; Pawlita M; Paltiel O
    PLoS One; 2020; 15(12):e0244712. PubMed ID: 33382786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological profiles in subgroups of patients with Sjögren's syndrome.
    Manoussakis MN; Tzioufas AG; Pange PJ; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():89-92. PubMed ID: 3473654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyautoimmunity in systemic lupus erythematosus: secondary Sjogren syndrome.
    Sieiro Santos C; Moriano Morales C; Álvarez Castro C; Díez Alvarez E
    Z Rheumatol; 2023 Jan; 82(Suppl 1):68-73. PubMed ID: 34287668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.